AXLA

Axcella Health Stock Price

3.57
-0.10 (-2.72%)
Upgrade to Real-Time
Afterhours (Closed)
3.57

Low
3.03

52 Week Range

High
6.84

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Axcella Health Inc AXLA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.10 -2.72% 3.57 18:00:14
Open Price Low Price High Price Close Price Prev Close
3.65 3.55 3.6999 3.57 3.67
Bid Price Ask Price Spread News
3.50 3.80 0.30 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
581 58,410 $ 3.61 $ 210,687 - 3.03 - 6.84
Last Trade Time Type Quantity Stock Price Currency
16:15:47 2 $ 3.63 USD

Period:

Draw Mode:

Axcella Health Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 130.12M 36.45M 10.90M $ - $ - -2.19 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 12.00 3.50%

more financials information »

Axcella Health News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AXLA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.623.903.453.6296,025-0.05-1.38%
1 Month4.154.813.454.10370,375-0.58-13.98%
3 Months4.305.903.034.45348,226-0.73-16.98%
6 Months6.006.843.034.63200,672-2.43-40.5%
1 Year4.626.843.034.86174,974-1.05-22.73%
3 Years15.1215.942.255.31138,314-11.55-76.39%
5 Years15.1215.942.255.31138,314-11.55-76.39%

Axcella Health Description

Axcella Health Inc a biotechnology company focused on treating complex diseases and improve health using endogenous metabolic modulator, or EMM, compositions. Its product candidates are comprised of multiple EMMs that are engineered in distinct combinations and ratios to simultaneously impact multiple biological pathways. The company's pipeline includes lead therapeutic candidates, AXA1665 for the reduction in risk of recurrent overt hepatic encephalopathy, and AXA1125 for non-alcoholic steatohepatitis.


Your Recent History
NASDAQ
AXLA
Axcella He..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.